162 related articles for article (PubMed ID: 34662257)
21. Formulation design and characterization of silymarin liposomes for enhanced antitumor activity.
Ke Z; Cheng X; Yang H; Niu Y; Cheng X; Ye T; Sun G; Cheng Z; Sun Y
Pak J Pharm Sci; 2024 Jan; 37(1):139-145. PubMed ID: 38741410
[TBL] [Abstract][Full Text] [Related]
22. Self-nanoemulsifying drug delivery systems ameliorate the oral delivery of silymarin in rats with Roux-en-Y gastric bypass surgery.
Chen CH; Chang CC; Shih TH; Aljuffali IA; Yeh TS; Fang JY
Int J Nanomedicine; 2015; 10():2403-16. PubMed ID: 25848259
[TBL] [Abstract][Full Text] [Related]
23. Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin.
Choi JS; Piao YJ; Kang KW
Arch Pharm Res; 2011 Apr; 34(4):607-13. PubMed ID: 21544726
[TBL] [Abstract][Full Text] [Related]
24. Co-encapsulation of docetaxel and cyclosporin A into SNEDDS to promote oral cancer chemotherapy.
Cui W; Zhao H; Wang C; Chen Y; Luo C; Zhang S; Sun B; He Z
Drug Deliv; 2019 Dec; 26(1):542-550. PubMed ID: 31090467
[TBL] [Abstract][Full Text] [Related]
25. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.
Hendrikx JJ; Lagas JS; Rosing H; Schellens JH; Beijnen JH; Schinkel AH
Int J Cancer; 2013 May; 132(10):2439-47. PubMed ID: 23090875
[TBL] [Abstract][Full Text] [Related]
26. Solid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability: In vitro and in vivo evaluation.
Inugala S; Eedara BB; Sunkavalli S; Dhurke R; Kandadi P; Jukanti R; Bandari S
Eur J Pharm Sci; 2015 Jul; 74():1-10. PubMed ID: 25845633
[TBL] [Abstract][Full Text] [Related]
27. Significance of aldo-keto reductase 1C3 and ATP-binding cassette transporter B1 in gain of irinotecan resistance in colon cancer cells.
Matsunaga T; Okumura N; Saito H; Morikawa Y; Suenami K; Hisamatsu A; Endo S; Ikari A
Chem Biol Interact; 2020 Dec; 332():109295. PubMed ID: 33096057
[TBL] [Abstract][Full Text] [Related]
28. Paclitaxel in self-micro emulsifying formulations: oral bioavailability study in mice.
Oostendorp RL; Buckle T; Lambert G; Garrigue JS; Beijnen JH; Schellens JH; van Tellingen O
Invest New Drugs; 2011 Oct; 29(5):768-76. PubMed ID: 20390333
[TBL] [Abstract][Full Text] [Related]
29. Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug.
Mohsin K; Alamri R; Ahmad A; Raish M; Alanazi FK; Hussain MD
Int J Nanomedicine; 2016; 11():2829-38. PubMed ID: 27366063
[TBL] [Abstract][Full Text] [Related]
30. Paeonol nanoemulsion for enhanced oral bioavailability: optimization and mechanism.
Chen S; Zhang J; Wu L; Wu H; Dai M
Nanomedicine (Lond); 2018 Feb; 13(3):269-282. PubMed ID: 29338580
[TBL] [Abstract][Full Text] [Related]
31. Quality by design approach for oral bioavailability enhancement of irbesartan by self-nanoemulsifying tablets.
Patel J; Dhingani A; Garala K; Raval M; Sheth N
Drug Deliv; 2014 Sep; 21(6):412-35. PubMed ID: 24215334
[TBL] [Abstract][Full Text] [Related]
32. Development and Optimization of Solid Self Nanoemulsifying Drug Delivery (S-SNEDDS) Using D-Optimal Design for Improvement of Oral Bioavailability of Amiodarone Hydrochloride.
Patel A; Shelat P; Lalwani A
Curr Drug Deliv; 2015; 12(6):745-60. PubMed ID: 25731867
[TBL] [Abstract][Full Text] [Related]
33. Enhanced oral bioavailability of lurasidone by self-nanoemulsifying drug delivery system in fasted state.
Miao Y; Sun J; Chen G; Lili R; Ouyang P
Drug Dev Ind Pharm; 2016 Aug; 42(8):1234-40. PubMed ID: 26582334
[TBL] [Abstract][Full Text] [Related]
34. Bioavailability enhancement and pharmacokinetic profile of an anticancer drug ibrutinib by self-nanoemulsifying drug delivery system.
Shakeel F; Iqbal M; Ezzeldin E
J Pharm Pharmacol; 2016 Jun; 68(6):772-80. PubMed ID: 27018771
[TBL] [Abstract][Full Text] [Related]
35. Development of a solid supersaturated self-nanoemulsifying preconcentrate (S-superSNEP) of fenofibrate using dimethylacetamide and a novel co-processed excipient.
Patki M; Patel K
Drug Dev Ind Pharm; 2019 Mar; 45(3):405-414. PubMed ID: 30444435
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo evaluation of self-nanoemulsifying drug delivery systems of cilostazol for oral and parenteral administration.
Mahmoud DB; Shukr MH; Bendas ER
Int J Pharm; 2014 Dec; 476(1-2):60-9. PubMed ID: 25269009
[TBL] [Abstract][Full Text] [Related]
37. Statistical modeling, optimization and characterization of solid self-nanoemulsifying drug delivery system of lopinavir using design of experiment.
Patel G; Shelat P; Lalwani A
Drug Deliv; 2016 Oct; 23(8):3027-3042. PubMed ID: 26882014
[TBL] [Abstract][Full Text] [Related]
38. Formulation optimization of Docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti-tumor activity.
Valicherla GR; Dave KM; Syed AA; Riyazuddin M; Gupta AP; Singh A; Wahajuddin ; Mitra K; Datta D; Gayen JR
Sci Rep; 2016 May; 6():26895. PubMed ID: 27241877
[TBL] [Abstract][Full Text] [Related]
39. Self-nanoemulsifying drug delivery systems of myricetin: Formulation development, characterization, and in vitro and in vivo evaluation.
Qian J; Meng H; Xin L; Xia M; Shen H; Li G; Xie Y
Colloids Surf B Biointerfaces; 2017 Dec; 160():101-109. PubMed ID: 28917148
[TBL] [Abstract][Full Text] [Related]
40. Characterization and evaluation of self-nanoemulsifying sustained-release pellet formulation of ziprasidone with enhanced bioavailability and no food effect.
Miao Y; Chen G; Ren L; Pingkai O
Drug Deliv; 2016 Sep; 23(7):2163-2172. PubMed ID: 25148542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
